Newtown, PA October 8, 2014 – Quotient Limited ("Quotient") (NASDAQ: QTNT), an established, commercial-stage diagnostics company, today announced the approval and launch of four new products to expand its reagent red cell product offering.
The four new products are:
- ALBAcyte® Expanded Rh Negative Antibody Screen
- ALBAcyte® Antibody Identification Panel (16-cell)
- ALBAcyte® Antibody Screen (2-cell)
- ALBAzyme® Papain Solution Kit